Abbreviations used in this paper: AB, Alcian blue; AEC, airway epithelial cell; BH, Bcl-2 homology; CT, control; DAP, death-associated protein; ERK, extracellular regulated kinase; HAEC, human AEC; MAEC, mouse AEC; shRNA, short hairpin RNA.

Introduction
============

Although it is well established that IFNγ causes cell death in a variety of cell types ([@bib13]; [@bib40]; [@bib63]; [@bib45]; [@bib54]; [@bib24]), the signal transduction downstream of STAT1 remains largely unknown ([@bib2]). Unraveling the role of IFNγ in apoptosis remains a challenge because IFNγ may prime cells to apoptosis and through induction of many genes can concomitantly elicit an antiproliferative and a proliferative state ([@bib65]). The decision between life and death may depend on possible costimuli or the cell type. Enhanced expression and translocation of Diablo into the cytosol play a critical role in the promotion of IFNγ-induced apoptosis of IFNγ-sensitive B cells ([@bib70]). Th1 cells that secrete high levels of IFNγ are more susceptible to activation-induced cell death than Th2 cells because Th2 cells express Fas-associated phosphatase, FAP-1 ([@bib73]). In keratinocytes, IFNγ induces apoptosis via increasing expression of Fas receptor ([@bib54]), whereas the Fas ligand--Fas receptor pathway is not involved in the IFNγ-induced death of primary human airway epithelial cells (AECs \[HAECs\]; [@bib47]; [@bib55]). IFNγ induces cell death in AECs ([@bib50]) to remove hyperplastic epithelial cells after inflammation-induced epithelial cell hyperplasia by activating STAT1 ([@bib47]), translocating Bax to the ER, and releasing ER calcium ([@bib51]; [@bib49]). Disruption of the IFNγ-induced elimination of hyperplastic epithelial cells can be the source for chronic mucous secretions in asthma ([@bib47]; [@bib41]) or for neoplastic growth over prolonged periods ([@bib72]).

The Bcl-2 family of proteins consists of members with three to four Bcl-2 homology (BH) regions such as the proapoptotic proteins Bax and Bak ([@bib33]) and the antiapoptotic members such as Bcl-2, Bcl-x~L~, and MCL-1. The interactions of these proteins are an essential gateway required for cell death in response to diverse stimuli ([@bib62]) and under a wide variety of circumstances, suggesting that they act at a central control (CT) point in the pathway to apoptotic cell death ([@bib1]; [@bib11]; [@bib53]). Another group of Bcl-2 family members contains only the BH3 motif and displays some selectivity for multiple domain Bcl-2 members ([@bib38]; [@bib31]) and provides a link between various cell death initiators and the execution machinery of apoptosis ([@bib9]; [@bib39]). BH3-only proteins inactivate the antiapoptotic proteins and allow activation of the multidomain proapoptotic members Bax and Bak ([@bib8]; [@bib37]; [@bib48]; [@bib64]). The proapoptotic activity of BH3-only molecules is kept in check by either p53-dependent transcriptional CT ([@bib60]), posttranslational modification ([@bib58]; [@bib30]), or by binding to the dynein light chain in myosin V filamentous actin and thereby being sequestered from binding to Bcl-2 ([@bib42]; [@bib12]).

Our goal for this study was to further characterize the IFNγ-induced cell death in AECs by identifying the BH3-only proteins involved in this pathway. Bik/Blk/Nbk was consistently induced by IFNγ, and its expression induced cell death. Loss of Bik but not p53, Bim, or Bax conferred resistance to IFNγ but not to thapsigargin-induced cell death. Primary mouse AECs (MAECs) from *p53*- but not *bik*-deficient mice were protected from DNA damage--induced cell death. We demonstrate that the conserved Leu residue within the BH3 domain of Bik is crucial for its cell death--inducing activity by interacting with and suppressing the nuclear localization of phospho--extracellular regulated kinase 1/2 (ERK1/2) in MAECs and HAECs. Furthermore, loss of Bik was accompanied by increased nuclear phospho-ERK1/2 and sustained epithelial cell hyperplasia in mouse airways, and blocking activated ERK1/2 with U0126 suppressed cell death in response to IFNγ treatment and Bik expression. Therefore, these experiments show that Bik is central in mediating IFNγ-induced cell death by retaining activated ERK1/2 in the cytosol in cultured AECs and during resolution of hyperplastic epithelial cells in mouse airways.

Results
=======

IFNγ induces Bik expression to elicit cell death in AECs
--------------------------------------------------------

We have previously shown that proliferating but not resting HAECs undergo apoptosis in response to IFNγ ([@bib47]) and that Bax plays a role in this cell death pathway ([@bib51]; [@bib49]). To identify which of the BH3-only proteins initiate IFNγ-induced cell death upstream of Bax, primary HAECs and AALEB cells, a cell line derived from HAECs, were treated with IFNγ for 12, 24, 48, 72, and 96 h, and the changed expression of all the BH3-only members of the Bcl-2 family of proteins was screened using quantitative RT-PCR. Significant induction was consistently observed for Bik, but Puma, Hrk, Bid, and Bad remained unchanged. Bik mRNA levels were induced at 24--96 h ([Fig. 1 A](#fig1){ref-type="fig"}), and Bik protein levels were increased at 24 h after IFNγ treatment ([Fig. 1 B](#fig1){ref-type="fig"}) and remained elevated over 96 h (not depicted).

![**IFNγ treatment induces Bik by activating STAT1 to cause cell death in AECs.** (A and B) HAECs were treated with IFNγ for the indicated times, and Bik expression was analyzed by quantitative RT-PCR (A) and Western blotting (B). The relative standard curve method was used for analysis of unknown samples, and data are presented as fold change after averaging the ΔCT values for the untreated samples. (C) *STAT1^+/+^* and *STAT1^−/−^* MAECs were treated with IFNγ for 24 h on Transwell culture inserts. Protein from harvested cells was immunoblotted with the indicated antibodies. (D) Detection of Bik in HBEC-2 cells infected with nothing (lane 1), Ad-Bik (lane 2), or Ad-Bik^L61G^ (lane 3) at 100 MOI by Western analysis. (E) HBEC-2 cells were infected with nothing, Ad-Bik, Ad-Bik^L61G^, or Ad-GFP, and cells were counted 24 h after infection. (F) HBEC-2 cells were infected with a retroviral expression vector for Bik shRNA or an empty vector and 24 h later were treated with 50 ng/ml IFNγ. Cells were harvested 48 h later for Western blot analysis with anti-Bik and antiactin antibodies, and cell counts were determined for IFNγ-treated cells infected with a CT vector or Bik shRNA expression retroviruses. Data presented are means ± SEM for three independent experiments. \*, P \< 0.05; statistically significant difference from the untreated CT.](jcb1830429f01){#fig1}

To determine whether Bik expression requires STAT1 activation, *STAT1^+/+^* and *STAT1^−/−^* MAECs were treated with IFNγ for 24 h, and cell extracts were analyzed for Bik expression. Results showed that Bik expression was significantly reduced in *STAT1^−/−^* compared with *STAT1^+/+^* MAECs ([Fig. 1 C](#fig1){ref-type="fig"}). Similarly, compared with Flag-expressing HBEC-2 cells, a significant reduction in Bik expression was observed in cells expressing a Flag-tagged dominant-negative construct for STAT1 that was previously shown to suppress IFNγ-induced cell death (unpublished data). However, p53, which has been shown to be important for inducing Bik ([@bib20]; [@bib35]), was not perceptibly affected in these cells ([Fig. 1 C](#fig1){ref-type="fig"}).

The BH3 domain of Bik is crucial for inducing death in proliferating epithelial cells
-------------------------------------------------------------------------------------

To investigate the role of Bik and the importance of the BH3 domain in inducing cell death, we expressed Bik adenoviral expression vector for Bik (Ad-Bik), mutant Bik (Ad-Bik^L61G^), or adenoviral expression vector for GFP (Ad-GFP) in the immortalized AEC line, HBEC-2, and HAECs using an adenoviral expression system at an MOI of 100 ([Fig. 1 D](#fig1){ref-type="fig"}). Ad-Bik expression reduced the number of HBEC-2 cells significantly ([Fig. 1 E](#fig1){ref-type="fig"}) compared with Ad-Bik^L61G^-- or Ad-GFP--infected cells with an equal amount of MOI. As was previously observed for IFNγ ([@bib47]), the ability of Bik to induce cell death was sensitive to cell growth conditions because confluent cultures of HBEC-2 cells or HAECs were unaffected by Ad-Bik infection, even though Bik expression was evident by Western blot analysis (unpublished data). To further investigate the role of Bik in IFNγ-induced cell death, IFNγ-induced Bik expression was suppressed in HAECs by infecting with a retroviral expression vector for Bik short hairpin RNA (shRNA), whereas CTs were infected with empty vector ([Fig. 1 F](#fig1){ref-type="fig"}). Suppression of IFNγ-induced Bik expression resulted in a significantly increased number of cells compared with cells infected with CT retrovirus ([Fig. 1 F](#fig1){ref-type="fig"}).

Overall, these studies showed that IFNγ induces cell death in AECs through Bik, although a previous study using *bik^−/−^* mice had shown that Bik has no role in hematopoietic cell death ([@bib10]). To determine whether Bik deficiency confers resistance to IFNγ-induced AEC death, we isolated MAECs from *bik^+/+^* and *bik^−/−^* mice and placed them in culture on Transwell membranes. As expected, Bik expression was induced by recombinant murine IFNγ at 24 h in *bik^+/+^* but not in *bik^−/−^* MAECs ([Fig. 2 A](#fig2){ref-type="fig"}). Consistent with the idea that IFNγ requires Bik to induce cell death, IFNγ significantly reduced the number of MAECs from wild-type but not from *bik^−/−^* mice ([Fig. 2 B](#fig2){ref-type="fig"}). MAECs from *p53^−/−^* mice died similarly to those from wild-type mice, whereas *bim^−/−^* or *bax^−/−^* MAECs appeared to be even more susceptible to IFNγ-induced cell death. IFNγ induced Bik expression in *p53^−/−^* MAECs ([Fig. 2 C](#fig2){ref-type="fig"}), suggesting that p53 is not a crucial player in the IFNγ-induced cell death process.

![***Bik^−/−^* MAECs are resistant to IFNγ-induced cell death.** (A) Western blot analysis shows that MAECs from *bik^+/+^* mice express Bik 24 h after IFNγ treatment, whereas *bik^−/−^* MAECs did not. (B) Primary MAECs isolated from *bik^−/−^*, *p53^−/−^*, *bax^−/−^*, *bim^−/−^*, and wild-type mice were placed in culture on Transwell membranes treated with 50 ng/ml recombinant murine IFNγ or were left untreated and counted 4 d later. MAECs from *p53^−/−^*, *bax^−/−^*, *bim^−/−^*, and wild-type mice showed significant reduction, whereas *bik^−/−^* AECs were unaffected. Data presented are means ± SEM for three independent experiments. (C) MAECs from *p53^−/−^* mice were either left untreated or were treated with IFNγ for 24 h, and protein extracts were analyzed for Bik expression by Western blotting. (D) *p53^−/−^*, *bik^−/−^*, and wild-type MAECs were treated with 0.5 μM adriamycin and counted at 0, 1, and 2 d. (E) *Bik^+/+^* and *bik^−/−^* MAECs were treated with 1 μM thapsigargin, and cell viability was determined at 0, 1, and 2 d. (F) *bik^+/+^* and *bik^−/−^* MAECs were treated with 50 ng/ml IFNγ, and cell viability was determined at 0, 1, and 2 d. (G and H) *Bik^−/−^* MAECs were either infected with Ad-GFP, Ad-Bik, or Ad-Bik^L61G^, and 24 h later protein extracts were analyzed for Bik expression by Western blotting (G) and cells were counted (H). Error bars indicate ± SEM. \*, P \< 0.05; statistically significant difference from the untreated CT.](jcb1830429f02){#fig2}

We next determined whether Bik deficiency affected the response of MAECs to proapoptotic stimuli other than IFNγ. Loss of Bik did not confer any protection on MAECs undergoing apoptosis after exposure to the DNA-intercalating agent adriamycin, whereas *p53^−/−^* MAECs were completely protected ([Fig. 2 D](#fig2){ref-type="fig"}). *Bik^+/+^* and *bik^−/−^* MAECs were also equally susceptible to thapsigargin ([Fig. 2 E](#fig2){ref-type="fig"}). As was previously reported that HAECs are resistant to FasL ([@bib19]; [@bib47]), treatment with FasL did not affect both *bik^−/−^* and *bik^+/+^* MAECs (unpublished data). Therefore, loss of Bik did not sensitize MAECs to FasL-induced cell death. However, consistent with the described experiments, Bik deficiency completely protected MAECs from IFNγ observed over a period of 48 h, whereas ∼50% of *bik^+/+^* MAECs died over this time period ([Fig. 2 F](#fig2){ref-type="fig"}). To further confirm that Bik is crucial for IFNγ-induced cell death, we reintroduced either wild-type Bik or mutant Bik into *bik^−/−^* MAECs using adenoviral infection and found significant cell death in *bik^−/−^* MAECs by expressing wild-type but not mutant Bik ([Fig. 2, G and H](#fig2){ref-type="fig"}).

Translocation of phosphatidylserine from the inner leaflet of the cell\'s membrane to the outer leaflet is an early event in apoptotic cells that allows binding to annexin V ([@bib59]). Treating HBEC-2 cells with IFNγ for 48 h consistently showed a significant increase of cells that are positive for propidium iodide and annexin V FITC compared with nontreated CTs ([Fig. 3 A](#fig3){ref-type="fig"}). Similarly, the percentages of early and late apoptotic cells as determined by annexin V and propidium iodide staining were significantly increased from 5.5 ± 0.8% to 23.6 ± 2%, and the percentage of viable cells was reduced from 91.8 ± 0.8% to 67.9 ± 3.4% at 24 h of infection with Ad-Bik^L61G^ and Ad-Bik, respectively ([Fig. 3 A](#fig3){ref-type="fig"}). To ensure that cells were infected with equal titers of the adenoviral vectors, Bik expression was analyzed by Western blotting, and infection with Ad-GFP showed minimal cell death (unpublished data).

![**INFγ and Bik induce annexin V positivity and expression of cathepsins B and D.** (A) HBEC-2 cells were either left untreated, were treated with IFNγ for 48 h, or were infected with Ad-Bik or Ad-Bik^L61G^ and stained for annexin V positivity. Representative figures of six independent experiments are shown. (B) HBEC-2 cells were treated with nothing or IFNγ or were infected with Ad-GFP, Ad-Bik^L61G^, or Ad-Bik, and mRNA levels for cathepsins B and D were assessed by RT-PCR. β-Actin mRNA expression was used as a loading CT, and expression levels were compared with CTs. A representative figure and the quantification of data expressed as mean ± SEM representing *n* = 3 for each group are shown. \*, P \< 0.05 compared with the respective CTs. (C) *bik^+/+^* and *bik^−/−^* MAECs were treated with 50 ng/ml IFNγ, and mRNA levels for cathepsins B and D were assessed by RT-PCR. β-Actin mRNA expression was used as a loading CT. (D) Annexin V positivity of *bik^−/−^* and *bik^+/+^* MAECs treated with 50 ng/ml IFNγ. NT, not treated.](jcb1830429f03){#fig3}

If Bik is crucial for IFNγ-induced cell death, we reasoned that the known downstream effectors for IFNγ-induced cell death would be identically induced by Bik. Cathepsins B and D are increased in expression by IFNγ and mediate the resulting cell death ([@bib14]; [@bib61]). Therefore, HBEC-2 cells were treated with IFNγ or nothing as a CT or were infected with Ad-Bik, Ad-Bik^L61G^, or GFP (Ad-GFP), and expression of cathepsins B and D was analyzed by RT-PCR. Both cathepsins B and D were reproducibly induced by both IFNγ and Ad-Bik but not by Ad-GFP or Ad-Bik^L61G^ or in untreated CTs ([Fig. 3 B](#fig3){ref-type="fig"}). In addition, treatment with IFNγ increased expression of cathepsins B and D ([Fig. 3 C](#fig3){ref-type="fig"}) and annexin V positivity ([Fig. 3 D](#fig3){ref-type="fig"}) significantly more in *bik^+/+^* compared with *bik^−/−^* MAECs, further confirming that Bik is a central mediator for this cell death pathway.

Bik blocks nuclear translocation of activated ERK1/2 to cause cell death
------------------------------------------------------------------------

A previous study showed that IFNγ-induced cell death of oligodendroglial cells requires ERK1/2 activation ([@bib24]). To determine the mechanisms of how Bik mediates IFNγ-induced cell death, extracts from HBEC-2 cells treated with IFNγ for 0, 1, 4, 8, 24, and 48 h were subjected to Western blot analysis. ERK1/2 was significantly activated 24 h after IFNγ treatment ([Fig. 4 A](#fig4){ref-type="fig"}), but the extent of ERK1/2 activation was similar in *bik^+/+^* and *bik^−/−^* MAECs when treated with IFNγ for 24 h and Bik expression was evident ([Fig. 4 B](#fig4){ref-type="fig"}), suggesting that Bik was not mediating ERK1/2 activation. Previous studies had demonstrated that nuclear ERK activation causes cells to proliferate, although cytosolic ERK is associated with cell death ([@bib29]; [@bib7]). Therefore, we examined the distribution of phospho-ERK1/2 in IFNγ-treated *bik^+/+^* and *bik^−/−^* MAECs and found that activated ERK1/2 was reduced in the nuclear extract of *bik^+/+^* compared with *bik^−/−^* MAECs ([Fig. 4 C](#fig4){ref-type="fig"}). To further confirm that Bik overexpression inhibits nuclear translocation of ERK1/2, primary HAECs were infected with nothing as a CT, Ad-Bik, Ad-Bik^L61G^, or Ad-GFP, and the cytosolic and nuclear extracts were analyzed by Western blotting 48 h later. We had previously observed that leaving the medium unchanged for 48 h caused sustained activation of ERK1/2 in HAECs (unpublished data). Although phospho-ERK1/2 was detected in the cytosolic extracts from CT and Ad-Bik--infected cells, phospho-ERK1/2 was absent in the nuclear fraction of Ad-Bik--infected HAECs but present in CT cells transfected with Ad-GFP-- and Ad-Bik^L61G^--infected cells ([Fig. 4 D](#fig4){ref-type="fig"}). To investigate whether Bik binds to activated ERK1/2 to inhibit its nuclear translocation, we performed immunoprecipitation assays with proteins extracted from HBEC-2 that were infected with Ad-GFP, Ad-Bik, or Ad-Bik^L61G^. Results showed that phospho-ERK1/2 is detected in pull-down products from Ad-Bik-- but not from Ad-Bik^L61G^-- or Ad-GFP--infected HBEC-2 cells ([Fig. 4 E](#fig4){ref-type="fig"}), suggesting that Bik directly interacts with phospho-ERK1/2 to sequester ERK1/2 in the cytoplasm.

![**Bik binds to activated ERK1/2 and inhibits its nuclear translocation.** (A) HBEC-2 cells were treated with 50 ng/ml human recombinant IFNγ, and ERK1/2 activation was assessed at 1, 4, 8, 24, and 48 h of IFNγ treatment. The ratio of phospho-ERK1/2 to total ERK1/2 at different time points after IFNγ treatment was quantified. (B) ERK1/2 activation in MAECs from *bik^+/+^* mice compared with those from *bik^−/−^* mice after IFNγ treatment. MAECs were treated with 50 ng/ml murine recombinant IFNγ for 24 h, and protein extracts were analyzed for Bik expression and phospho-ERK1/2. (C) Nuclear extract from IFNγ-treated *bik^+/+^* and *bik^−/−^* MAECs was analyzed for activated ERK1/2. (D) Translocation of phospho-ERK1/2 is inhibited by Bik expression in primary HAECs. HAECs were either left untreated or were infected with Ad-Bik, Ad-Bik^L61G^, or Ad-GFP at an MOI of 100, and ERK1/2 was activated by maintaining cells in unchanged media for 48 h. Nuclear and cytosolic extracts were analyzed for phospho-ERK1/2, total ERK1/2, Bik, lamin, and actin. The figure is representative of three independent experiments. (E) Bik interacts with phospho-ERK1/2. Cell lysates prepared from HBEC-2 cells infected with either Ad-GFP, Ad-Bik, or Ad-Bik^L61G^ were immunoprecipitated with anti-Bik antibody. The cell lysates (input) and immunoprecipitates were resolved by SDS-PAGE and analyzed by Western blotting using antibodies to Bik, phospho-ERK1/2, and total ERK1/2. (F) Representative photomicrographs and quantification showing that a higher percentage of MAECs from *bik^−/−^* compared with *bik^+/+^* mice displays nuclear localization of activated ERK1/2. MAECs were treated with 50 ng/ml IFNγ for 24 h, fixed in paraformaldehyde, and immunostained for phospho-ERK1/2. The percentage of nuclei with phospho-ERK was quantified from three independent experiments. Bar, 10 μm. (G) HBEC-2 cells were infected with 100 MOI Ad-Bik and were cotreated with 1 μM U0126, the ERK-specific inhibitor. Cells infected with Ad-Bik showed a 60% decline in total cell number, and this decline was diminished when the HBEC-2 cells were cotreated with 0.1 or 1 μM U0126. The corresponding Western blot of proteins extracted from cells infected with Ad-Bik and treated with U0126 to suppress ERK1/2 activation. (H) Cell counts and Western blot analysis of protein extracted from HBEC-2 cells that were left untreated or treated with IFNγ either alone or with U0126. Treatment with 1 μM U0126 did not affect cell growth. NT, not treated. Error bars indicate group means ± SEM (*n* = 4 different treatments per group). \*, P \< 0.05; significantly different from Ad-Bik--infected cells.](jcb1830429f04){#fig4}

Immunofluorescence staining showed that the percentage of cells with nuclear phospho-ERK1/2 was significantly higher in *bik^−/−^* MAECs compared with that observed in *bik^+/+^* MAECs after 24 h of IFNγ treatment ([Fig. 4 F](#fig4){ref-type="fig"}). These results demonstrate that expression of Bik suppresses nuclear translocation of activated ERK1/2 and that the conserved Leu residue in the BH3 domain of Bik is crucial for the inhibition of translocation. Activated ERK1/2 in the presence of Bik was proapoptotic because Ad-Bik--induced cell death was suppressed by the ERK1/2 inhibitor U0126 ([Fig. 4 G](#fig4){ref-type="fig"}). Western blot analysis showed that in the presence of U0126, the levels of activation of cytosolic ERK1/2 were dramatically reduced in AECs infected with Ad-Bik ([Fig. 4 G](#fig4){ref-type="fig"}). Similarly, U0126 significantly attenuated IFNγ-induced reduction of cell numbers and suppressed IFNγ-induced cytosolic ERK1/2 activation ([Fig. 4 H](#fig4){ref-type="fig"}). Together, these experiments demonstrate that IFNγ through Bik inhibits nuclear translocation of activated ERK1/2 and that cytosolic ERK1/2 is proapoptotic.

Bik mediates removal of hyperplastic epithelial cells in mouse airways
----------------------------------------------------------------------

Repeated exposure to allergen results in proliferation and epithelial cell hyperplasia associated with the mucous phenotype; however, when mice are continuously exposed for periods beyond 10 d, epithelial cell hyperplasia decreases ([@bib51]). Our previous experiments showed that IFNγ and STAT1 signaling are central for the resolution of allergen-induced epithelia cell hyperplasia ([@bib49]). Because Bik was central for IFNγ-induced AEC death, we investigated whether this resolution process would be abrogated in *IFNγ^−/−^* and *bik^−/−^* mice. Interestingly, epithelial cell hyperplasia in *IFNγ^−/−^* airways after 5 d of allergen exposure was reduced compared with wild-type and *bik^−/−^* mice, suggesting that IFNγ plays a role in the allergen-induced proliferation of airway cells ([Fig. 5, A and B](#fig5){ref-type="fig"}). However, as expected, resolution of epithelial cell hyperplasia was abrogated in both *IFNγ^−/−^* ([Fig. 5 A](#fig5){ref-type="fig"}) and *bik^−/−^* ([Fig. 5, B and C](#fig5){ref-type="fig"}) mice during 15 d of allergen exposure, although it was significantly reduced in wild-type mice. Furthermore, the number of mucous cells per millimeter of basal lamina was significantly reduced in *bik^+/+^* mice compared with *bik^−/−^* mice during 12 and 15 d of allergen exposure ([Fig. 5, D and E](#fig5){ref-type="fig"}), confirming that Bik is central for IFNγ-induced killing in mouse airways as was observed in cultured MAECs. The role of Bik in inhibiting nuclear translocation of ERK1/2 was investigated by assessing the distribution of phospho-ERK1/2 in lung tissues of *bik^+/+^* and *bik^−/−^* mice at 5, 12, and 15 d of allergen exposure. Nuclear phospho-ERK1/2 was detected in airway cells of both *bik^+/+^* and *bik^−/−^* mice exposed to allergen for 5 d but in significantly higher percentages in *bik^−/−^* airways at 12 and 15 d of exposure ([Fig. 5 F](#fig5){ref-type="fig"}). Interestingly, primarily the mucus-containing cells showed immunostaining for nuclear phospho-ERK1/2. Total ERK1/2 was found to be distributed similarly in both *bik^+/+^* and *bik^−/−^* mouse lungs after exposure to allergen for 5, 12, or 15 d. These findings show that Bik expression suppresses nuclear translocation of phospho-ERK1/2 in airways when resolution of hyperplastic epithelial cells occurs.

![**IFNγ and Bik are crucial for the resolution of epithelial cell hyperplasia and mucous cell metaplasia during prolonged exposure to allergen.** Mice were immunized with ovalbumin/alum on days 1 and 7 and were exposed to ovalbumin aerosols for 5, 12, or 15 d. After sacrifice, the lungs of each mouse were fixed under constant pressure perfusion and cut in 4-mm slices from distal to caudal. Slices were embedded in paraffin, and tissue sections were stained with hematoxylin and eosin or AB/periodic acid Schiff to count the total cell number or mucous cell per millimeter of basal lamina, respectively. (A and B) The number of epithelial cells per millimeter of basal lamina was significantly reduced in wild-type mice but not in IFNγ^−/−^ (A) or *bik^−/−^* (B) mice at 15 d of exposure. Error bars indicate ± SEM. (C) Representative micrographs from *bik^+/+^*- and *bik^−/−^*-sensitized mice exposed to allergen for 5, 12, and 15 d display that the density of epithelial cell nuclei is reduced in *bik^+/+^* but not in *bik^−/−^* airways. (D) The number of mucous cells per millimeter of basal lamina was significantly reduced in *bik^+/+^* but not in *bik^−/−^* mice. (E) Representative micrographs from *bik^+/+^* and *bik^−/−^* mice. Error bars indicate group means ± SEM (*n* = 5 mice per group). (F) Representative photomicrographs and quantification showing that activated ERK1/2 is found in the nuclei in *bik^+/+^* and *bik^−/−^* mice exposed to allergen for 5 d, but nuclear phospho-ERK is only observed in airways of *bik^−/−^* mice at 12 and 15 d. Arrows denote nuclear phospho-ERK1/2. Error bars indicate group means ± SEM (*n* = 3 mice/group). Representative photomicrographs showing that total ERK1/2 is uniformly distributed in airways from *bik^+/+^* and *bik^−/−^* mice exposed to allergen for 5, 12, and 15 d. \*, P \< 0.05; significantly different from wild-type CTs.](jcb1830429f05){#fig5}

Discussion
==========

IFNγ-induced Bik expression and cell death requires STAT1 but is independent of p53
-----------------------------------------------------------------------------------

Our studies suggest that IFNγ-induced activation of STAT1 causes Bik expression because IFNγ failed to induce Bik expression in *STAT1^−/−^* MAECs, and the same truncation mutant of STAT1 that reduced IFNγ-induced Bik expression also significantly reduced IFNγ-induced cell death of AECs ([@bib49]). The findings from the present study in *bik^−/−^* mice together with our previous findings that allergen-induced airway epithelial hyperplasia is sustained in *STAT1^−/−^* mice ([@bib49]) places STAT1 activation upstream of Bik. Whether STAT1 activation leads to increased Bik promoter activity or causes stabilization of Bik mRNA is currently unclear. Support for direct interaction and activation of the Bik promoter by STAT1 could be based on the presence of seven STAT-binding consensus sequences, TTNCNNNAA ([@bib5]), including two tandem sites within the core Bik promoter ([@bib57]). However, our attempts to stimulate a Bik promoter luciferase construct with IFNγ were not successful, suggesting that other transcription factors or mRNA stability may play a critical role in the induction of Bik expression by IFNγ. Overall, the findings suggest that although STAT1 may affect many signaling pathways in vivo, its activation requires Bik expression to channel the apoptotic effect.

Several observations show that the pathway by which IFNγ induces cell death does not involve the p53 pathway. (1) Resistance of *bik^−/−^* MAECs to IFNγ did not include the resistance to adriamycin that is mediated by DNA damage and p53 activation. (2) During IFNγ-induced cell death, p53 levels were not affected in AECs. (3) IFNγ induced Bik expression in *p53^−/−^* MAECs, suggesting that IFNγ does not require p53 to induce Bik expression and cell death. Similarly, others have reported that Bik mediates cell death in the p53-deficient H1299 cells and does not require p53 ([@bib35]).

Loss of Bik mediates resistance to IFNγ but not to other cell death inducers
----------------------------------------------------------------------------

IFNγ induces Bik expression that is localized to the ER ([@bib36]), translocates Bax to the ER, and elicits ER stress as shown by release of ER calcium stores ([@bib49]) by JNK activation and induction of CHOP levels (unpublished data). Bax plays a role in IFNγ-induced cell death ([@bib51]), but *bax^−/−^* MAECs succumb to IFNγ treatment, suggesting that Bak can substitute for the loss of Bax as was reported previously ([@bib33]; [@bib62]). In fact, data from the present studies suggest that loss of Bim or Bax may sensitize MAECs more to IFNγ-induced cell death. Future studies need to investigate the role of Bim and Bax in the IFNγ-induced expression of Bik and/or the ER-stress pathway.

*Bik^−/−^* MAECs are resistant to IFNγ-induced ER stress, although they are sensitive to thapsigargin, a selective inhibitor of the ER-associated Ca^2+^-ATPase that allows Ca^2+^ to flow from the ER lumen into the cytoplasm. This sensitivity may be the result of IFNγ causing activation of ER stress and calcium release by mechanisms different from those induced by thapsigargin or because the ER-associated Ca^2+^-ATPase may be downstream of Bik. IFNγ and Bik-induced ER stress may be caused by the inactivation of GRP78 (BiP), an ER-associated protein that has antiapoptotic properties ([@bib18]). Bik binds to GRP78 and allows the release of the critical transmembrane ER signaling proteins PERK, Ire1, and ATF6 ([@bib66]). Protein shutdown caused by the bacterial toxin MazF or cycloheximide was also shown to require Bik to mediate cell death in TRex-293 cells ([@bib48]). It is possible that inhibition of protein synthesis causes Bik expression by blocking the proteasome degradation system and results in massive ER stress through the GRP78 system.

Bik blocks nuclear translocation of activated ERK1/2 to cause cell death
------------------------------------------------------------------------

In HAECs, IFNγ activated ERK1/2 24 h after treatment, which coincides with the time of Bik expression. ERK1/2 activation was also associated with IFNγ-induced death in oligodendroglial cells ([@bib24]). Because ERK1/2 activation was similar in cytosolic extracts from *bik^+/+^* and *bik^−/−^* MAECs, we started to analyze whether Bik may affect the localization of phospho-ERK1/2. Both Western blot and immunofluorescence analyses confirmed that the presence of nuclear ERK1/2 was suppressed when Bik was expressed. Not only IFNγ- but also starvation-induced phospho-ERK1/2 was inhibited from translocating to the nucleus when Bik was present. The conserved Leu residue in the BH3 domain that was crucial for Bik-induced cell death was also crucial for interacting and inhibiting phospho-ERK1/2 translocation. Furthermore, inhibition of ERK1/2 using U0126 suppressed IFNγ- and Bik-induced cell death, suggesting that cytosolic ERK1/2 is proapoptotic, whereas nuclear ERK1/2 promotes growth in AECs. The biological consequence of ERK activation in a given cell may be determined by the cell-specific cytosolic or nuclear substrates. ERK is generally considered to be antiapoptotic ([@bib28]) but can function as a stimulator of apoptosis in cells expressing death-associated protein (DAP) kinase ([@bib7]), a kinase that promotes the cytoplasmic retention of ERK1/2. DAP-kinase was isolated from HeLa cells as a mediator of IFNγ-induced cell death ([@bib13]; [@bib32]), but its role in affecting the BH3-only proteins is not known. DAP-kinase is constitutively expressed in human HAECs and MAECs (unpublished data). Therefore, IFNγ-induced ERK1/2 activation and Bik expression may initiate a feedback loop that initiates DAP-kinase--mediated cytoplasmic retention of ERK1/2 to promote the amplification of proapoptotic signals. Bik was shown to interact with Bcl-2 ([@bib4]), but this interaction is not sufficient for its apoptotic function ([@bib16]). The present studies show that the proapoptotic function of Bik stems from its ability to inhibit nuclear translocation of phospho-ERK1/2.

The mechanisms of how Bik expression may induce expression of cathepsins B and D are unclear. Cathepsin B contains a TATA-less promoter but an E box that allows the formation of a transcription initiation complex involving the upstream stimulatory factors USF1 and ISF2 ([@bib69]). Other transcription factors, including Ets1, Sp1, and EBS, regulate expression at two alternative promoters ([@bib68]; [@bib67]). The TATA-containing promoter of cathepsin D is regulated by the hormone estrogen ([@bib6]). Future studies will investigate whether Bik regulates expression of these mRNAs by reducing nuclear translocation of phospho-ERK1/2 that may have an inhibitory effect on these promoters or by increasing cytosolic phospho-ERK1/2 and prolonging mRNA half-life.

IFNγ can be proliferative but requires Bik to channel death
-----------------------------------------------------------

Exposure to allergen caused more AEC hyperplasia in *bik^−/−^* and wild-type mice compared with *IFNγ^−/−^* mice, suggesting that IFNγ plays a role in the proliferation of epithelial cells. However, once the hyperplastic stage was established, the resolution was abrogated in both *IFNγ^−/−^* and *bik^−/−^* mice. Such a double-sided effect for IFNγ has been previously reported ([@bib21]; [@bib44]; [@bib65]); however, this study demonstrates that IFNγ requires Bik to channel its cell death--inducing activity. So far, the murine Bik has only been suggested to represent a homologous equivalent of human Bik. The present studies show a role of human and murine Bik as the main mediator for IFNγ-induced cell death and, therefore, suggest that they are functionally homologous.

Although Bik is expressed in the liver, lung, heart, and kidneys and in granulocytes, macrophages, and developing as well as mature T and B lymphocytes ([@bib10]), the *bik^−/−^* mice develop and age normally, suggesting that IFNγ-induced cell killing is not required during normal development under injury- and pathogen-free conditions. Loss of Bik conferred no protection to mature T and B cells from spontaneous death in culture, from treatment with dexamethasone or etoposide, or from cytokine starvation of mitogen-activated B cells ([@bib10]). Bik inducing death in AECs rather than hematopoietic cells may result from airway cells expressing other genes such as DAP-kinase to facilitate Bik-mediated suppression of nuclear translocation of phospho-ERK1/2. The cell type--specific effect of BH3-only domain proteins is further supported by our previous studies showing that Bim, an essential initiator of apoptosis in negative selection of autoreactive thymocytes ([@bib3]), and B cells ([@bib17]), are not involved in the resolution of airway epithelial hyperplasia ([@bib41]).

The present studies show that loss of Bik or IFNγ leads to sustained epithelial cell hyperplasia after allergen-induced inflammation in mouse airways. In addition, proliferating rather than nonproliferating, resting AECs are prone to undergo cell death in response to IFNγ treatment or Bik overexpression. Therefore, Bik is ineffective in inducing cell death in confluent airway epithelial cultures (unpublished data). Primarily the mucus-containing cells showed nuclear phospho-ERK1/2 in lung tissues of mice exposed to allergen. Several studies have shown that after injury to the airway epithelium, a large proportion of the hyperplastic and cycling cells are secretory cells ([@bib25],[@bib26],[@bib27]). Because mucous cells are the hyperplastic cells ([@bib52]), they may be by default susceptible to cell death and elimination in vivo during resolution. Susceptibility of proliferating cells to IFNγ or Bik-induced cell death may be a mechanism to selectively target hyperplastic epithelial cells that in airways usually represent mucus-producing cells ([@bib29]). This selective elimination of only hyperplastic cells may ensure that resting AECs maintain the barrier function of the airway epithelium, may allow the CT of mucus production, and may prevent the development of cancerous lesions. Therefore, restoring Bik expression may be useful for eliminating hyperplastic airway cells. Bik was first identified as a protein that interacts with the adenoviral protein E1B 19K ([@bib20]; [@bib35]). The reason for E1B 19K or the viral homologue encoded by Epstein-Barr virus, BHRF1, singling out Bik for inhibition may be to sustain the viability of the host cells and promote replication and release of virus particles.

In summary, our analyses of HAECs and MAECs in culture and in airways of intact mice identify Bik as the central mediator of IFNγ-induced apoptosis. Furthermore, we provide evidence that Bik induces cell death by inhibiting nuclear translocation of activated ERK1/2 in a pathway that is independent of p53.

Materials and methods
=====================

Animals
-------

Male-specific pathogen-free wild-type C57BL/6J and *p53^+/−^* mice were purchased from The Jackson Laboratory. Mice were housed in isolated cages under specific pathogen-free conditions. After a 14-d quarantine period, mice were acclimatized for 8 d and entered into the experimental protocol at 8--10 wk of age. The *bax^+/−^*, *bim^+/−^*, and *bik^+/−^* mice on C57BL/6 background were provided by S. Korsmeyer (Dana Farber Research Institute, Boston, MA) and A. Strasser (Walter and Eliza Hall Institute, Melbourne, Australia). *Bax^+/+^* and *bax^−/−^*, *p53^+/+^* and *p53^−/−^*, and *bim^−/−^* with *bim^+/+^* and *bik*^+/+^ with *bik*^−/−^ littermates were bred from the respective heterozygote mice at the Lovelace Respiratory Research Institute under specific pathogen-free conditions and genotyped as described previously ([@bib10]). *STAT1^−/−^* on C57BL/6 background were purchased from Taconic. All experiments were approved by the Institutional Animal Care and Use Committee and were performed at the Lovelace Respiratory Research Institute, a facility approved by the Association for the Assessment and Accreditation for Laboratory Animal Care International. Sensitization and exposure of mice to ovalbumin were performed as described previously ([@bib51]). Preparation of lung tissues for histopathological examination was performed as described previously ([@bib47]). Tissue sections were stained with Alcian blue (AB) and periodic acid Schiff or hematoxylin and eosin as described previously ([@bib47]). The number of AB-positive cells per millimeter of basal lamina was quantified using a light microscope (BH-2; Olympus) equipped with the Image analysis system (National Institutes of Health) as described previously ([@bib22]).

Cells
-----

MAECs were harvested and cultured on Transwell membranes (Corning) after seeding with 4 × 10^4^ or 9 × 10^4^ cells as previously described ([@bib71]). Cell viability was determined by trypan blue exclusion. Primary HAECs were purchased from Cambrex Bio Science Walkersville, Inc. The immortalized HAECs, AALEB, and HBEC-2 cells provided by S. Randell (University of North Carolina Chapel Hill, Chapel Hill, NC) and J. Shay (University of Texas Southwestern, Dallas, TX) were described previously ([@bib34]; [@bib43]). Cells were maintained in bronchial epithelial growth medium supplemented with growth factors as described previously ([@bib47]).

Adenoviral expression vectors for Bik and Bik^L61G^ were provided by G. Shore (McGill University, Montreal, Quebec, Canada), and cells were infected as described previously ([@bib35]). The MAPK extracellular signal-regulated kinase inhibitor 4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio) butadiene (U0126) was purchased from EMD. The doxorubicin hydrochloride (adriamycin) was purchased from Thermo Fisher Scientific, and thapsigargin was purchased from Tocris Bioscience. Viability was assessed by trypan blue exclusion.

Retroviral silencing with Bik shRNA
-----------------------------------

Retroviral silencing vector encoding for Bik shRNA and the CT vector were purchased from Origene Technologies, Inc. The suppressing effect of the shRNA was established in HBEC-2 cells, and amplification and purification of plasmid DNA and packaging of the retroviral particles in Phoenix cells were performed as specified by the manufacturer\'s instructions. After infection with Bik or CT shRNAs, HBEC-2 cells were treated with 50 ng/ml human recombinant IFNγ, and 48 h later cells were harvested for Western blot analysis.

RT-PCR
------

For quantitative RT-PCR, the primer/probe sets (Applied Biosystems) were distributed into each well in duplicates, and target mRNAs were amplified by PCR in 20-μl reactions. Preamplification efficiency was assessed by performing amplification of nonamplifed cDNA with TaqMan Gene Expression Assays (Applied Biosystems). For all reactions, CT values \>37 were eliminated for evaluation of preamplification efficiency. Uniform preamplification was demonstrated by a ΔΔCT value of −1.5 to 1.5 when comparing the CT values of each gene amplified from preamplified and nonamplified cDNA as described previously ([@bib46]). Because all results were derived from the linear amplification curve, the use of the ΔΔCT method ensures that only mRNA amplification within the linear range was compared.

For semiquantitative RT-PCR, total RNA was extracted from HBEC-2 cells with TRIZOL (TRI Reagent; Invitrogen), first-strand cDNA was synthesized using an oligo(dT) primer and Omniscript reverse transcription (QIAGEN), and PCR for human and murine cathepsins B and D was conducted using the primers and conditions described previously ([@bib15]; [@bib56]). Amplified PCR products were quantified via densitometry using Fluor-S-Max Imager and Quantity One software (Bio-Rad Laboratories). Band intensities were normalized with the corresponding band intensities for β-actin.

Immunofluorescence and immunohistochemistry
-------------------------------------------

Lung tissue sections were deparaffinized, rehydrated, washed, and, after antigen retrieval, incubated with the respective primary and secondary antibodies as described previously ([@bib23]). Procedures for detection of ERK1/2 by immunofluorescence using rabbit antiphospho-ERK1/2 antibody and rabbit anti-ERK1/2 antibody (Cell Signaling Technology) at a 1:100 dilution and with a secondary goat anti--rabbit conjugated to Alexa Fluor 647 and the counterstain with Hoechst were described previously ([@bib49]). Immunofluorescence was imaged using Axioplan 2 (Carl Zeiss, Inc.) with a Plan-Aprochromal 63×/1.4 oil objective and a charge-coupled device camera (SensiCAm; PCO), and the acquisition software used was digital microscopy software (Slidebook 4.2; Intelligent Imaging Innovation). Immunohistochemical stains were imaged using a microscope (Eclipse E600W; Nikon) with a Plan Fluor 60× NA 0.85 objective and a digital camera (DXM1200F; Nikon) with ACT-1 acquisition software (version 2.62; Nikon).

Western blot analysis
---------------------

Protein lysates were prepared and analyzed by Western blotting as described previously ([@bib51]). Cytosolic and nuclear fractions were prepared by lysing cells in NP-40 to obtain the cytosolic fraction and extracting the nuclear proteins with a hypertonic extraction buffer (50 mM Hepes, pH 7.8, 50 mM KCl, and 300 mM NaCl) in the presence of protease and phosphatase inhibitors as described previously ([@bib49]). The following antibodies were used: goat anti-Bik polyclonal antibody (Santa Cruz Biotechnology, Inc.), rabbit antiphospho-ERK1/2 antibody, and rabbit anti-ERK1/2 antibody (Cell Signaling Technology). Total ERK1/2 was detected with anti-ERK1/2 antibodies (1:1,000) in the same membrane used for antiphospho-ERK1/2 and total ERK1/2 antibodies, respectively, after deprobing. Equal protein loading was confirmed by subsequent probing with the mouse monoclonal antibody against actin (Santa Cruz Biotechnology, Inc.).

Pull-down assay
---------------

A size X protein A immunoprecipitation kit (Thermo Fisher Scientific) was used to cross-link 50 μg of purified anti-Bik antibody to protein A beads using disuccinmidyl suberate as described by the manufacturer. Bik-associated proteins were immunoprecipitated by incubating protein lysates prepared from Ad-GFP--, Ad-Bik--, or Ad-Bik^L61G^--infected HBEC-2 cells with gentle mixing at 4°C overnight. After repeated washes, proteins bound to the Bik antibody on beads were eluted with 0.2 ml of ImmunoPure Elution buffer (Thermo Fisher Scientific) and analyzed by Western blotting and antiphospho-ERK1/2 and anti-Bik antibodies.

Statistical analysis
--------------------

Grouped results from at least four different mice were expressed as means ± SEM. Data were analyzed using statistical analysis software (Statistical Analysis Software Institute). Results grouped by time point and genotype were analyzed using two-way analysis of variance. When significant main effects were detected (P \< 0.05), Fisher\'s least significant difference test was used to determine the differences between groups. A p-value of 0.05 was considered to indicate statistical significance.
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